logo-rectanglelogo-rectanglelogo-rectanglelogo-rectangle
  • Home
  • About us
  • Our services
  • Rayan Hospitals
    • Heidelberg University Hospital
    • ETHIANUM Hospital
    • Atos hospitals
    • The University Hospital of Munich (LMU)
    • University Hospital of Freiburg
    • Frankfurt University Hospital
    • Charité Hospital in Berlin
    • SRH Hospital in Carlsbad
    • Rehamed Heidelberg Physiotherapy Center in Heidelberg, Germany
    • Celenus Gotthard Schettler Clinic
    • The Celenus Sigmund Weil Clinic
  • Translation services
  • Blogs
  • Contact us
  • English
Chat Us
✕
Published by شركة ريان للخدمات الطبية والسياحة العلاجية فى المانيا on May 26, 2020
Categories
  • News
Tags

A possible vaccine against the strain of coronavirus causing the COVID-19 pandemic has seen early signs of success in China. However, we are “still a long way from a vaccine for all,” a Beijing scientist warned.

A possible vaccine against SARS-COV-2, the strain of coronavirus that causes COVID-19, has been shown to be at least partially effective, a Chinese study published Friday confirmed.

The study showed that a particular active substance triggered an immune response to the SARS-COV-2 virus in the human body. Further experiments are necessary to find out if the reaction would also prevent infection with the virus in the first place.

“These results represent an important milestone,” said Professor Wei Chen who was responsible for the study at the Beijing Institute of Biotechnology.

The study, published in medical journal Lancet, proved that the active substance Ad5-nCoV was safe and well-tolerated. The active substance is the biologically active ingredient of any drug or immunization.

Vaccine efforts a mix of competition and cooperation

Scientists advise “cautious” interpretation

The phase 1 trial involved the substance being administered to 108 healthy volunteers in Hubei province, the original epicenter of the outbreak.

“The Ad5 vectored COVID-19 vaccine is tolerable and immunogenic at 28 days post vaccination,” the authors of the study wrote. A final evaluation will be made after six months. A double-blind study with a control group has already been started as a phase trial.

However, Wei was quick to advise “caution” on interpreting the results too optimistically.

“A promising vision for the development of COVID-19 vaccines is emerging, but we are still a long way from a vaccine that is accessible to all,” he said. The results should be interpreted “cautiously,” he added.

The Lancet estimates that around 100 potential active substances are in development worldwide, including in the UK where a huge vaccine test of over 10,000 people will begin soon.

Share

Related posts

March 17, 2021

5 reasons to seek treatment in Germany


Read more
May 26, 2020

How Germany contained the coronavirus


Read more
May 26, 2020

Coronavirus: Over 40 Covid-19 cases traced to church service in Germany


Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Home
  • About us
  • Our services
  • Rayan Hospitals
    • Heidelberg University Hospital
    • ETHIANUM Hospital
    • Atos hospitals
    • The University Hospital of Munich (LMU)
    • University Hospital of Freiburg
    • Frankfurt University Hospital
    • Charité Hospital in Berlin
    • SRH Hospital in Carlsbad
    • Rehamed Heidelberg Physiotherapy Center in Heidelberg, Germany
    • Celenus Gotthard Schettler Clinic
    • The Celenus Sigmund Weil Clinic
  • Translation services
  • Blogs
  • Contact us
  • English

Recent Posts

  • 5 reasons to seek treatment in Germany
  • PROF. DR. MED. HELMUT K. SEITZ
  • DR. MED. SYLVIA PROSKE
  • PROF. DR. MED. AMADEUS HORNEMANN
  • PROF. DR. MED. JÖRG HOLSTEIN
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    
  • → Home
  • → About us
  • → Services
  • → Hospitals
  • → Contact Us

أحدث المقالات

  • 0
    5 reasons to seek treatment in Germany
    March 17, 2021
  • 0
    PROF. DR. MED. HELMUT K. SEITZ
    July 1, 2020
  • 0
    DR. MED. SYLVIA PROSKE
    July 1, 2020
CALL US

004917672262942

OR WRITE

info@rayan-medical.com

© 2020 ريان للخدمات الطبية والسياحة العلاجية. جميع الحقوق محفوظة. Ah Designers.
Chat Us
  • No translations available for this page
  • English